Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 53

1.

Human endometriotic lesion expression of the miR-144-3p/miR-451a cluster, its correlation with markers of cell survival and origin of lesion content.

Nothnick WB, Swan K, Flyckt R, Falcone T, Graham A.

Sci Rep. 2019 Jun 19;9(1):8823. doi: 10.1038/s41598-019-45243-7.

2.

Macrophage Migration Inhibitory Factor Receptor, CD74, is Overexpressed in Human and Baboon ( Papio Anubis) Endometriotic Lesions and Modulates Endometriotic Epithelial Cell Survival and Interleukin 8 Expression.

Nothnick WB, Falcone T, Olson MR, Fazleabas AT, Tawfik OW, Graham A.

Reprod Sci. 2018 Nov;25(11):1557-1566. doi: 10.1177/1933719118766262. Epub 2018 Mar 28.

3.

Future Directions in Endometriosis Research and Therapeutics.

Nothnick WB, Marsh C, Alali Z.

Curr Womens Health Rev. 2018;14(2):189-194. doi: 10.2174/1573404813666161221164810.

4.

MicroRNAs and Endometriosis: Distinguishing Drivers from Passengers in Disease Pathogenesis.

Nothnick WB.

Semin Reprod Med. 2017 Mar;35(2):173-180. doi: 10.1055/s-0037-1599089. Epub 2017 Feb 17. Review.

5.

Serum miR-451a Levels Are Significantly Elevated in Women With Endometriosis and Recapitulated in Baboons ( Papio anubis) With Experimentally-Induced Disease.

Nothnick WB, Falcone T, Joshi N, Fazleabas AT, Graham A.

Reprod Sci. 2017 Aug;24(8):1195-1202. doi: 10.1177/1933719116681519. Epub 2016 Dec 5.

6.
7.

Non-coding RNAs in Uterine Development, Function and Disease.

Nothnick WB.

Adv Exp Med Biol. 2016;886:171-189. doi: 10.1007/978-94-017-7417-8_9. Review.

8.

Transgelin, a Novel Marker of Smooth Muscle Differentiation, Effectively Distinguishes Endometrial Stromal Tumors from Uterine Smooth Muscle Tumors.

Tawfik O, Rao D, Nothnick WB, Graham A, Mau B, Fan F.

Int J Gynecol Obstet Reprod Med Res. 2014 Sep;1(1):26-31.

9.

Transgelin: a potentially useful diagnostic marker differentially expressed in triple-negative and non-triple-negative breast cancers.

Rao D, Kimler BF, Nothnick WB, Davis MK, Fan F, Tawfik O.

Hum Pathol. 2015 Jun;46(6):876-83. doi: 10.1016/j.humpath.2015.02.015. Epub 2015 Mar 10.

10.

Circulating Micro-RNAs as Diagnostic Biomarkers for Endometriosis: Privation and Promise.

Nothnick WB, Al-Hendy A, Lue JR.

J Minim Invasive Gynecol. 2015 Jul-Aug;22(5):719-26. doi: 10.1016/j.jmig.2015.02.021. Epub 2015 Mar 7. Review.

12.

Endometriosis: bright future for a cloudy past?

Nothnick WB.

Sci Transl Med. 2015 Jan 21;7(271):271fs2. doi: 10.1126/scitranslmed.aaa5075. Review.

PMID:
25609165
13.

miR-451 deficiency is associated with altered endometrial fibrinogen alpha chain expression and reduced endometriotic implant establishment in an experimental mouse model.

Nothnick WB, Graham A, Holbert J, Weiss MJ.

PLoS One. 2014 Jun 17;9(6):e100336. doi: 10.1371/journal.pone.0100336. eCollection 2014.

14.

Loss of the repressor REST in uterine fibroids promotes aberrant G protein-coupled receptor 10 expression and activates mammalian target of rapamycin pathway.

Varghese BV, Koohestani F, McWilliams M, Colvin A, Gunewardena S, Kinsey WH, Nowak RA, Nothnick WB, Chennathukuzhi VM.

Proc Natl Acad Sci U S A. 2013 Feb 5;110(6):2187-92. doi: 10.1073/pnas.1215759110. Epub 2013 Jan 2.

15.

The role of micro-RNAs in the female reproductive tract.

Nothnick WB.

Reproduction. 2012 May;143(5):559-76. doi: 10.1530/REP-11-0240. Epub 2012 Mar 27. Review.

PMID:
22454533
17.
18.

The emerging use of aromatase inhibitors for endometriosis treatment.

Nothnick WB.

Reprod Biol Endocrinol. 2011 Jun 21;9:87. doi: 10.1186/1477-7827-9-87. Review.

19.

Steroidal regulation of uterine miRNAs is associated with modulation of the miRNA biogenesis components Exportin-5 and Dicer1.

Nothnick WB, Healy C, Hong X.

Endocrine. 2010 Apr;37(2):265-73. doi: 10.1007/s12020-009-9293-9.

20.

Estrogen induces distinct patterns of microRNA expression within the mouse uterus.

Nothnick WB, Healy C.

Reprod Sci. 2010 Nov;17(11):987-94. doi: 10.1177/1933719110377472. Epub 2010 Aug 18.

21.

Endometriosis: in search of optimal treatment.

Nothnick WB.

Minerva Ginecol. 2010 Feb;62(1):17-31. Review.

PMID:
20186112
22.

Future targets in endometriosis treatment: targeting the endometriotic implant.

Nothnick WB, Zhang X.

Mini Rev Med Chem. 2009 Mar;9(3):324-8. Review.

PMID:
19275725
23.

Hyperphagia and obesity in female mice lacking tissue inhibitor of metalloproteinase-1.

Gerin I, Louis GW, Zhang X, Prestwich TC, Kumar TR, Myers MG Jr, Macdougald OA, Nothnick WB.

Endocrinology. 2009 Apr;150(4):1697-704. doi: 10.1210/en.2008-1409. Epub 2008 Nov 26.

24.

Regulation of uterine matrix metalloproteinase-9 and the role of microRNAs.

Nothnick WB.

Semin Reprod Med. 2008 Nov;26(6):494-9. doi: 10.1055/s-0028-1096129. Epub 2008 Oct 24. Review.

25.

Dicer1 is essential for female fertility and normal development of the female reproductive system.

Hong X, Luense LJ, McGinnis LK, Nothnick WB, Christenson LK.

Endocrinology. 2008 Dec;149(12):6207-12. doi: 10.1210/en.2008-0294. Epub 2008 Aug 14.

27.

Regulation of MMP-9 expression and activity in the mouse uterus by estrogen.

Zhang X, Christenson LK, Nothnick WB.

Mol Reprod Dev. 2007 Mar;74(3):321-31.

PMID:
16967517
28.

The relevancy of the matrix metalloproteinase system to the pathophysiology of endometriosis.

Zhou HE, Nothnick WB.

Front Biosci. 2005 Jan 1;10:569-75. Print 2005 Jan 1. Review.

PMID:
15574393
29.

The role and regulation of the uterine matrix metalloproteinase system in menstruating and non-menstruating species.

Zhang X, Nothnick WB.

Front Biosci. 2005 Jan 1;10:353-66. Print 2005 Jan 1. Review.

PMID:
15574374
30.

Novel targets for the treatment of endometriosis.

Nothnick WB.

Expert Opin Ther Targets. 2004 Oct;8(5):459-71. Review.

PMID:
15469395
31.

Matrix metalloproteinases and their tissue inhibitors in the developing neonatal mouse uterus.

Hu J, Zhang X, Nothnick WB, Spencer TE.

Biol Reprod. 2004 Nov;71(5):1598-604. Epub 2004 Jul 7.

PMID:
15240428
32.
33.
34.

Medical management of endometriosis: novel targets and approaches towards the development of future treatment regimes.

Nothnick WB, D'Hooghe TM.

Gynecol Obstet Invest. 2003;55(4):189-98. Review.

PMID:
12904691
36.
38.

Treating endometriosis as an autoimmune disease.

Nothnick WB.

Fertil Steril. 2001 Aug;76(2):223-31. Review.

PMID:
11476764
39.

CD44s expression is reduced in endometriotic lesions compared to eutopic endometrium in women with endometriosis.

Nothnick WB, Fan F, Iczkowski KA, Ashwell R, Thomas P, Tawfik OW.

Int J Gynecol Pathol. 2001 Apr;20(2):140-6.

PMID:
11293159
41.

Collagenase and gelatinase messenger ribonucleic acid expression and activity during follicular development in the rat ovary.

Cooke RG 3rd, Nothnick WB, Komar C, Burns P, Curry TE Jr.

Biol Reprod. 1999 Nov;61(5):1309-16.

PMID:
10529279
46.
48.

Mifepristone and ovarian function.

Curry TE Jr, Nothnick WB.

Clin Obstet Gynecol. 1996 Jun;39(2):486-97. Review.

PMID:
8734013
50.

Expression and activity of ovarian tissue inhibitors of metalloproteinases during pseudopregnancy in the rat.

Nothnick WB, Edwards DR, Leco KJ, Curry TE Jr.

Biol Reprod. 1995 Sep;53(3):684-91.

PMID:
7578694

Supplemental Content

Loading ...
Support Center